TCL Archive Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs June 16, 1999
TCL Archive In Brief: Edwards Takes A Parting Shot At Cancer Program; “Forward Plan” Calls For Emphasis On Prevention January 17, 1975
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases August 26, 2011
TCL Archive Chi Van Dang Named Director of University Of Pennsylvania Abramson Cancer Center July 15, 2011
